A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Peter J. Neumann, ScD
Advertisement
Articles by Peter J. Neumann, ScD
Advertisement
Latest Updated Articles
- Findings Related to Assessing Value for Private US Health Plans
Published: July 14th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
5
